FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) ...

  Рет қаралды 2,670

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Listen to an audio podcast of the September 12th, 2024 FDA Drug Safety Communication on rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause.

Пікірлер
How FDA Investigates Foodborne Illness Outbreaks
12:08
U.S. Food and Drug Administration
Рет қаралды 56 М.
Players vs Pitch 🤯
00:26
LE FOOT EN VIDÉO
Рет қаралды 126 МЛН
Walking on LEGO Be Like... #shorts #mingweirocks
00:41
mingweirocks
Рет қаралды 7 МЛН
How to Safely Dispose of Unused or Expired Medicine
2:49
U.S. Food and Drug Administration
Рет қаралды 1,6 М.
FDA Drug Topic Webinar - Bad Ad Program
45:29
U.S. Food and Drug Administration
Рет қаралды 528
October 31, 2024 Endocrinologic and Metabolic Drugs Advisory Committee
9:05:10
U.S. Food and Drug Administration
Рет қаралды 7 М.
Improving the Quality of Life for People with Sickle Cell Disease
27:26
U.S. Food and Drug Administration
Рет қаралды 924
MEDIA CALL: FDA’s Proposed Order on Phenylephrine - 11/7/2024
13:14
U.S. Food and Drug Administration
Рет қаралды 574
REACHing Communities Video Series - An Interview with Myra Parker, J.D., M.P.H., Ph.D.
8:28
U.S. Food and Drug Administration
Рет қаралды 489
Innovating Generic Drug Research | Researching FDA
1:09
U.S. Food and Drug Administration
Рет қаралды 2,2 М.
Toward Improving Race and Ethnicity Data in Health Care
12:34
U.S. Food and Drug Administration
Рет қаралды 2,3 М.